Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Adamis

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Ophthalmology|May 2, 2006
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials, Donald J D'Amico, H N Masonson, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
Transscleral delivery of bioactive protein to the choroid and retinaJ Ambati, E S Gragoudas, J W Miller, et al.
American Journal of Ophthalmology|October 15, 1994
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyA P Adamis, J W Miller, M T Bernal, et al.
Australian and New Zealand Journal of Ophthalmology|August 1, 1996
Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factorM S Loughman, K Chatzistefanou, E M Gonzalez, et al.
The British Journal of Ophthalmology|July 11, 2008
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trialL J Singerman, H Masonson, M Patel, et al.
Current Eye Research|January 10, 2001
VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-AP Hofman, H G Blaauwgeers, M J Tolentino, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1995
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogenD T Shima, A P Adamis, N Ferrara, et al.
Ophthalmology|November 1, 1996
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primateM J Tolentino, J W Miller, E S Gragoudas, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetesF C Barouch, K Miyamoto, J R Allport, et al.
Biochemical and Biophysical Research Communications|June 15, 1993
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cellsA P Adamis, D T Shima, K T Yeo, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Ophthalmology|May 2, 2006
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials, Donald J D'Amico, H N Masonson, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
Transscleral delivery of bioactive protein to the choroid and retinaJ Ambati, E S Gragoudas, J W Miller, et al.
American Journal of Ophthalmology|October 15, 1994
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyA P Adamis, J W Miller, M T Bernal, et al.
Australian and New Zealand Journal of Ophthalmology|August 1, 1996
Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factorM S Loughman, K Chatzistefanou, E M Gonzalez, et al.
The British Journal of Ophthalmology|July 11, 2008
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trialL J Singerman, H Masonson, M Patel, et al.
Current Eye Research|January 10, 2001
VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-AP Hofman, H G Blaauwgeers, M J Tolentino, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1995
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogenD T Shima, A P Adamis, N Ferrara, et al.
Ophthalmology|November 1, 1996
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primateM J Tolentino, J W Miller, E S Gragoudas, et al.
Investigative Ophthalmology & Visual Science|February 7, 2001
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetesF C Barouch, K Miyamoto, J R Allport, et al.
Biochemical and Biophysical Research Communications|June 15, 1993
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cellsA P Adamis, D T Shima, K T Yeo, et al.
Pageof 7